Muscarinic Acetylcholine Receptor M2 抗体
-
- 抗原 See all Muscarinic Acetylcholine Receptor M2 (CHRM2) 抗体
- Muscarinic Acetylcholine Receptor M2 (CHRM2) (Cholinergic Receptor, Muscarinic 2 (CHRM2))
-
适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This Muscarinic Acetylcholine Receptor M2 antibody is un-conjugated
-
应用范围
- Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunocytochemistry (ICC)
- 预测反应
- Human
- 免疫原
- Recombinant human ChRM2.
- 克隆位点
- N8F12
- Top Product
- Discover our top product CHRM2 Primary Antibody
-
-
- 应用备注
-
WB 1:300-5000
IHC-P 1:200-400
IF()
ICC 1:100-500 - 限制
- 仅限研究用
-
- 浓度
- 0.5 μg/μL
- 缓冲液
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- 储存液
- ProClin
- 注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- 4 °C,-20 °C
- 储存方法
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- 有效期
- 12 months
-
- 抗原
- Muscarinic Acetylcholine Receptor M2 (CHRM2) (Cholinergic Receptor, Muscarinic 2 (CHRM2))
- 别名
- CHRM2 (CHRM2 产品)
- 别名
- HM2 antibody, AChR-M2 antibody, Chrm-2 antibody, M2 antibody, chrm2 antibody, Acm2 antibody, GPM2 antibody, cholinergic receptor muscarinic 2 antibody, cholinergic receptor, muscarinic 2, cardiac antibody, cholinergic receptor, muscarinic 2a antibody, cholinergic receptor, muscarinic 2 antibody, CHRM2 antibody, Chrm2 antibody, chrm2a antibody
- 背景
-
Synonyms: 7TM receptor, Acetylcholine receptor, muscarinic, 2, Acm2, Cholinergic receptor muscarinic 2, Cholinergic receptor, muscarinic 2, cardiac, Cholinergic receptor, muscarinic 2, isoform a, Cholinergic receptor, muscarinic 2a, Cholinergic receptor, muscarinic 2, isoform a, CHRM 2, chrm2a, CM2, FLJ43243, HM 2, HM2, M2, M2 muscarinic receptor, MGC120006, MGC120007, ACM2_HUMAN, Muscarinic acetylcholine receptor M2, Muscarinic M2 receptor, Acetylcholine receptor(M2).
Background: The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Primary transducing effect is adenylate cyclase inhibition.
- 基因ID
- 1129
- UniProt
- P08172
-